Trust Asset Management’s Moderna MRNA Stock Holding History

Trust Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$271K	Buy	+3,866	New	+$200K	0.02%	206
2024 Q4	–	Sell	-3,828	Closed	-$256K	–	233
2024 Q3	$256K	Hold	3,828	–	–	0.02%	197
2024 Q2	$455K	Hold	3,828	–	–	0.04%	135
2024 Q1	$408K	Hold	3,828	–	–	0.04%	147
2023 Q4	$381K	Hold	3,828	–	–	0.04%	148
2023 Q3	$395K	Hold	3,828	–	–	0.04%	137
2023 Q2	$465K	Hold	3,828	–	–	0.05%	125
2023 Q1	$588K	Sell	3,828 -98	-2%	-$16.2K	0.07%	101
2022 Q4	$705K	Hold	3,926	–	–	0.09%	88
2022 Q3	$464K	Buy	3,926 +226	+6%	+$34.3K	0.06%	112
2022 Q2	$529K	Buy	3,700 +179	+5%	+$25.6K	0.07%	101
2022 Q1	$607K	Buy	3,521 +164	+5%	+$27.6K	0.07%	101
2021 Q4	$853K	Hold	3,357	–	–	0.11%	81
2021 Q3	$1.29M	Buy	+3,357	New	+$1.24M	0.18%	55

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Trust Asset Management's MRNA Position: Q2 2026 in Review

Trust Asset Management opened a new position in Moderna (MRNA) in Q2 2026: 3,866 shares worth $271K. The stake represents 0.02% of the portfolio and ranks #206 among its holdings. This is a return to the name: Trust Asset Management previously reported a position in MRNA as recently as Q3 2024.

Trust Asset Management first reported a position in MRNA in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.29M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Trust Asset Management held 3,866 shares of Moderna worth $271K as of Q2 2026.
Moderna was a new Trust Asset Management position in Q2 2026.
Moderna made up 0.02% of Trust Asset Management's portfolio in Q2 2026, its #206 holding.
Trust Asset Management first reported a position in Moderna in Q3 2021 and has held it in 14 quarters since.
Trust Asset Management's Moderna position peaked at $1.29M in Q3 2021.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Trust Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.